Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.
about
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor CellsMyeloid-derived suppressor cells as regulators of the immune systemMyeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.AACR centennial series: the biology of cancer metastasis: historical perspectiveResisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomasMyeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytesAdoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cellsInteractome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerGM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor.Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.Tumor macrophage redox and effector mechanisms associated with hypoxiaRole of immature myeloid cells in mechanisms of immune evasion in cancer.Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor functionAbrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancerOverexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.Inflammation: a driving force speeds cancer metastasisAttenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation.Camouflage and sabotage: tumor escape from the immune system.Amino acid metabolism related to immune tolerance by MDSCs.Inflammation fuels tumor progress and metastasis.Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody.Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cellsImplication of stem cells in the biology and therapy of head and neck cancerIn vivo heparan sulfate treatment alters the immune response of normal and LLC-bearing mice.Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas.
P2860
Q26752515-0F33664D-08D0-417A-BAF5-84CE5041085EQ27345430-5F00BA05-1BF4-4A63-B3EC-3A718428A8AEQ28131637-39A6C4B3-C7DC-46C2-9264-960DB9362D60Q33584867-456A106B-6692-477D-9C1F-F3ECC484B5ADQ33683443-8D399F2A-7CCF-432E-B8C7-8EBE566DECBEQ33685705-F6B7D7BA-8C72-46FD-AC3F-DBF366195557Q33757576-DEA34F1B-10C0-4423-A86B-BA82081082CBQ34411361-88570BB4-4703-4434-8C7A-BB1B7E022056Q34877332-D8744037-8A93-4D1C-86DE-E6F56A675864Q34956969-A0B2BB34-8856-4712-B5E5-375EFD9D1843Q34983887-F79A6CC2-A997-4DEB-BF68-A482FE098789Q35207756-1666EFE3-A8B6-4743-BC39-2ABB448C0E2FQ35207759-7D519F78-CDF6-4321-97A3-AEE0354BBA40Q35721147-B74C8747-B2DA-4EF4-B7CD-4B7393C11FB5Q35915614-2EADF8BE-A51C-4AB0-9A21-A688A60D61E0Q35915769-6C2295C4-A593-4D1C-AB0A-A74808A2A748Q35916747-9C3BDBDC-D896-4A46-89B6-E4C9542411BBQ36208862-68B648C6-7C9B-417F-9F2A-A127E4D5F680Q36384598-100DA74D-F5DC-4996-A583-E96A8E83E5A2Q36464443-2F01C839-C401-4C36-BE9E-28CC3CA30EF8Q36489379-699B1EF1-EA4D-4576-9222-42B1A67D3EBDQ36597391-6527F895-4F8A-4EAE-ABDD-1084D5C115CCQ36982546-CCC7AC2D-F3F7-4D51-ADB2-5E21E09F5582Q36986448-9853D636-C75A-4288-8E09-B959AD465DE1Q37227206-E10FA7B1-C60E-48EC-AEA4-E42A62D616A7Q37500347-1389BD07-7A3B-4E34-8161-5DE52A1E818FQ37882478-B5BCCFCF-7A70-4A48-B901-84E457D0BF86Q38010200-8B2334D9-87A6-4125-B104-CD84BF0CDFB3Q38500455-80B4DDC4-19C4-4F0E-B857-75A7BD173830Q39376252-CD119F7A-03E9-4E06-A3B2-FEE03558C5B1Q39619917-52B89DD3-B211-439D-87D6-C0AC2858E298Q39970527-0A543BF1-ACD8-4B96-AF85-055CFFAF38BBQ40011425-C5408FF6-E16F-4DED-AA43-00ADBEF33163Q40614034-DF1BCCAE-9C1A-4C44-8E23-FE3201E3A432Q40978947-4B40CF2E-C990-4C9B-82C0-5316C4812D98Q42114592-06A7205F-793F-44E6-AE5D-01679D23E94AQ42143399-40FF7529-1275-4D6A-9E95-622E5CEE14C2Q42495070-79F1B9B5-D5BE-4731-BEEF-7D4B3B15F694Q46375692-4B9F939A-57F9-4C4D-9F9A-EAA152C6049AQ46743215-7D303849-047D-4D5D-9F4A-93D22BD14864
P2860
Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Myeloid progenitor cells media ...... ts with head and neck cancers.
@ast
Myeloid progenitor cells media ...... ts with head and neck cancers.
@en
type
label
Myeloid progenitor cells media ...... ts with head and neck cancers.
@ast
Myeloid progenitor cells media ...... ts with head and neck cancers.
@en
prefLabel
Myeloid progenitor cells media ...... ts with head and neck cancers.
@ast
Myeloid progenitor cells media ...... ts with head and neck cancers.
@en
P1476
Myeloid progenitor cells media ...... ts with head and neck cancers.
@en
P2093
P304
P356
10.1016/S0192-0561(99)00008-9
P577
1999-04-01T00:00:00Z